High materiality7/10
Bioventus price target raised to $19 from $15 at Canaccord
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity lifts BVS target to $19; current price $14.26. Upside potential remains.
- Target $19 vs price $14.26; bullish.
Key facts
- 01
Target: $19
- 02
Posted price: $14.26
- 03
Analyst firm: Canaccord Genuity
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.